Minerva Neurosciences (NERV)
Develops roluperidone for negative symptoms of schizophrenia through a confirmatory Phase 3 trial.
$3.62
vs last close−0.19 (−4.99%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 88.87% | 42.43M shares | |
|---|---|---|---|
| 59 holders · as of Jun 30, 2026 | |||
| Insiders | 0.68% | 322.8K shares | |
| 3 holders · as of Aug 20, 2026 | |||
| Strategic holders | 9.13% | 4.36M shares | |
| 2 holders · as of May 15, 2026 | |||
| Other | 1.32% | 633.7K shares | |
| remainder | |||
47.75M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
59 holders · 42.43M shares · 25 new positions · 40 increased · 9 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Federated Hermes, Inc. | 4.67M | 9.78% | −442.8K | Aug 12, 2026 |
| Jupiter Topco LLC | 4.39M | 9.19% | +4.39Mnew | Aug 14, 2026 |
| Vivo Capital, LLC | 4.32M | 9.05% | 0 | Aug 14, 2026 |
| Balyasny Asset Management L.P. | 4.26M | 8.92% | −1.6K | Aug 14, 2026 |
| Logos Global Management LP | 3.29M | 6.89% | +73.8K | Aug 14, 2026 |
| Farallon Capital Management LLC | 2.37M | 4.95% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 2.24M | 4.69% | +1.62M | Aug 7, 2026 |
| Ally Bridge Group (NY) LLC | 2.18M | 4.56% | +520.3K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Federated Hermes, Inc. | 19.86% | 9.39M | 13G | Dec 29, 2025 |
| Voting Shares Irrevocable Trustincl. Thomas R. Donahue, Federated Hermes, Inc. +2 more | 19.32% | 1.35M | 13D | Oct 28, 2025 |
| Balyasny Asset Management L.P. | 9.99% | 4.32M | 13G | May 15, 2026 |
| Coastlands Capital LP | 9.99% | 4.56M | 13G | Feb 20, 2026 |
| Vivo Opportunity Fund Holdings, L.P. | 9.99% | 8.59M | 13G | Dec 31, 2025 |
| Janus Henderson Group PLC | 9.90% | 4.31M | 13G | May 15, 2026 |
| Logos Global Management LP | 9.90% | 4.44M | 13G | Feb 17, 2026 |
| Adage Capital Management, L.P. | 6.35% | 2.84M | 13G | Feb 12, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.